期刊
JOURNAL OF IMMUNOLOGY
卷 204, 期 9, 页码 2575-2588出版社
AMER ASSOC IMMUNOLOGISTS
DOI: 10.4049/jimmunol.1901213
关键词
-
类别
资金
- National Key Research and Development Program of China [2016YFC1303500, 2018YFC1313400]
- National Natural Science Foundation of China [U1804281, 81771781]
Metformin has been studied for its anticancer effects by regulating T cell functions. However, the mechanisms through which metformin stimulates the differentiation of memory T cells remain unclear. We found that the frequencies of memory stem and central memory T cells increased for both in peripheral and tumor-infiltrating CD8(+) T cells in metformin-treated lung cancer patients compared with those not taking the medication. An in vitro assay showed that metformin promoted the formation of memory CD8(+) T cells and enhanced their antiapoptotic abilities. In addition, AMP-activated protein kinase (AMPK) activation decreased microRNA-107 expression, thus enhancing Eomesodermin expression, which suppressed the transcription of PDCD1 in metformin-treated CD8(+) T cells. In the CAR-T cell therapy model, metformin also exhibited cytotoxicity-promoting effects that led to decreased tumor growth. Metformin could reprogram the differentiation of CD8(+) T cells, which may benefit the clinical therapy of cancer patients by facilitating long-lasting cytotoxic functions.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据